Fig. 2. Antibacterial activity of (Glc)Ent–Amp against five E. coli strains. (a)–(e) Antibacterial activity of (Glc)Ent–Amp 5/7/9 against (a) uropathogenic E. coli CFT073, (b) uropathogenic E. coli UTI89, (c) non-pathogenic clinical isolate E. coli H9049, (d) laboratory strain E. coli K-12, (e) laboratory strain E. coli B. All assays were performed in 50% MHB medium supplemented with 200 μM DP (t = 19 h, T = 30 °C) (mean ± standard deviation, n ≥ 3). The data for (Glc)Ent–Amx 6/8/10 and for the assays performed in the absence of DP are presented in Fig. S5–S9.† .
